Search

Your search keyword '"Zeng, Haikang"' showing total 10 results
Start Over Author "Zeng, Haikang"
10 results on '"Zeng, Haikang"'

3. Choice of surgical procedure – lobectomy, segmentectomy, or wedge resection – for patients with stage T1‐2N0M0 small cell lung cancer: A population‐based study

Author

Liu, Yang, primary, Shan, Lanlan, additional, Shen, Jianfei, additional, Liu, Liping, additional, Wang, Jinlin, additional, He, Jiaxi, additional, He, Qihua, additional, Jiang, Long, additional, Guo, Minzhang, additional, Chen, Xuewei, additional, Zeng, Haikang, additional, Xia, Xiaojun, additional, Peng, Guilin, additional, Liang, Wenhua, additional, and He, Jianxing, additional

Published
2019
Full Text
View/download PDF

4. Long Non-Coding RNAs Suppressed Cell Cycle in Lung Adenocarcinoma

Author

Zhang, Jiexia, primary, Chen, Cheng, additional, Menglin Chen, Allen, additional, Zheng, Zhouxia, additional, Huang, Kailing, additional, Wen, Shuai, additional, Zeng, Haikang, additional, Liang, Annan, additional, Zhang, Yichi, additional, Cai, Kaican, additional, and Li, Jin, additional

Published
2019
Full Text
View/download PDF

10. [Prognostic Analysis of Lobectomy versus Sublobar Resection in Patients Aged ≥60 Years with Stage Ia Small Cell Lung Cancer].

Author

Zeng H, Liu Y, Xia X, Li J, and He J

Subjects
Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Lung Neoplasms diagnosis, Lung Neoplasms surgery, Pneumonectomy, Small Cell Lung Carcinoma diagnosis, Small Cell Lung Carcinoma surgery
Abstract

Background: Currently, the prognosis of lobectomy and sub-lobectomy for the treatment of stage Ia small cell lung cancer (SCLC) is rarely reported. We retrospectively studied T1N0M0 (≤3 cm) SCLC patients aged ≥60 years, aiming to comparatively analyze the prognosis of lobectomy and sub-lobectomy in treating patients with Ia SCLC., Methods: Patients with stage Ia SCLC diagnosed by pathologic between 1992 and 2010 were selected from the "Surveillance, Epidemiology and End Results database"(SEER). Outcome data were compared using Kaplan-Meier (Log-rank test) and Cox model multivariate analysis., Results: We identified 515 patients. Median overall survival (OS) of the lobectomy (n=110), sublobar resection (n=57) and non-surgical (n=348) cohort were 45, 23 and 16 months, respectively. The corresponding 5-year OS of the three groups were 44%, 30%, and 14%, respectively. No significant difference in the prognosis of patients with or without lymph node examination/ dissection (P=0.107) and the 5-year OS of patients underwent lobectomy with chemoradiation was 50%. Cox multivariable analysis showed that operation treatment, including lobectomy and sublobectomy, was one of the independent factors associated with the prognosis of early SCLC patients, and patients undergo lobectomy shows a better OS compared with sublobar resection (Lob vs Sub, HR=0.645; 95%CI: 0.433-0.961, P=0.031)., Conclusions: For age ≥60 years T1N0M0 (≤3 cm) SCLC patients, we recommend anatomical lobectomy combined with adjuvant chemoradiation.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results